A Mathematical Model for the Reciprocal Differentiation of T Helper 17 Cells and Induced Regulatory T Cells

被引:62
|
作者
Hong, Tian [1 ]
Xing, Jianhua [2 ]
Li, Liwu [2 ]
Tyson, John J. [2 ]
机构
[1] Virginia Polytech Inst & State Univ, Genet Bioinformat & Computat Biol Program, Blacksburg, VA 24061 USA
[2] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA
基金
美国国家科学基金会;
关键词
ROR-GAMMA-T; TRANSCRIPTION FACTORS; LINEAGE-COMMITMENT; TGF-BETA; PROINFLAMMATORY IL-17(+); PROGENITOR CELLS; DECISION-MAKING; RETINOIC ACID; T(H)17; INFLAMMATION;
D O I
10.1371/journal.pcbi.1002122
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The reciprocal differentiation of T helper 17 (T(H)17) cells and induced regulatory T (iT(reg)) cells plays a critical role in both the pathogenesis and resolution of diverse human inflammatory diseases. Although initial studies suggested a stable commitment to either the T(H)17 or the iT(reg) lineage, recent results reveal remarkable plasticity and heterogeneity, reflected in the capacity of differentiated effectors cells to be reprogrammed among T(H)17 and iT(reg) lineages and the intriguing phenomenon that a group of naive precursor CD4(+) T cells can be programmed into phenotypically diverse populations by the same differentiation signal, transforming growth factor beta. To reconcile these observations, we have built a mathematical model of T(H)17/iT(reg) differentiation that exhibits four different stable steady states, governed by pitchfork bifurcations with certain degrees of broken symmetry. According to the model, a group of precursor cells with some small cell-to-cell variability can differentiate into phenotypically distinct subsets of cells, which exhibit distinct levels of the master transcription-factor regulators for the two T cell lineages. A dynamical control system with these properties is flexible enough to be steered down alternative pathways by polarizing signals, such as interleukin-6 and retinoic acid and it may be used by the immune system to generate functionally distinct effector cells in desired fractions in response to a range of differentiation signals. Additionally, the model suggests a quantitative explanation for the phenotype with high expression levels of both master regulators. This phenotype corresponds to a re-stabilized co-expressing state, appearing at a late stage of differentiation, rather than a bipotent precursor state observed under some other circumstances. Our simulations reconcile most published experimental observations and predict novel differentiation states as well as transitions among different phenotypes that have not yet been observed experimentally.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis
    Iannello, Andrea
    Rolla, Simona
    Maglione, Alessandro
    Ferrero, Giulio
    Bardina, Valentina
    Inaudi, Ilenia
    De Mercanti, Stefania
    Novelli, Francesco
    D'Antuono, Lucrezia
    Cardaropoli, Simona
    Todros, Tullia
    Turrini, Maria Vittoria
    Cordioli, Cinzia
    Puorro, Giorgia
    Marsili, Angela
    Lanzillo, Roberta
    Morra, Vincenzo Brescia
    Cordero, Francesca
    De Bortoli, Michele
    Durelli, Luca
    Visconti, Andrea
    Cutrupi, Santina
    Clerico, Marinella
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [32] Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata
    Han, Yu-Mei
    Sheng, You-Yu
    Xu, Feng
    Qi, Si-Si
    Liu, Xiao-Jing
    Hu, Rui-Ming
    Miao, Ying
    Huang, Gui-Qin
    Yang, Qin-Ping
    JOURNAL OF DERMATOLOGY, 2015, 42 (10): : 981 - 988
  • [33] Thymol as a reciprocal regulator of T cell differentiation: Promotion of regulatory T cells and suppression of Th1/Th17 cells
    Namdari, Haideh
    Izad, Maryam
    Rezaei, Farhad
    Amirghofran, Zahra
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 67 : 417 - 426
  • [34] RESVERATROL IN COMBINATION WITH RETINOIC ACID SUPPRESSES EAE BY RECIPROCAL DIFFERENTIATION OF REGULATORY T CELLS AND TH17 CELLS
    Singh, N.
    Nagarkatti, M.
    Nagarkatti, P.
    JOURNAL OF NEUROCHEMISTRY, 2009, 108 : 140 - 141
  • [35] T follicular helper cells, T follicular regulatory cells and autoimmunity
    Zhu, Yangyang
    Zou, Le
    Liu, Yun-Cai
    INTERNATIONAL IMMUNOLOGY, 2016, 28 (04) : 173 - 179
  • [36] T helper 17 and T helper 1 cells are increased but regulatory T cells are decreased in subchondral bone marrow microenvironment of patients with rheumatoid arthritis
    Wang, Ting
    Li, Shufeng
    Yang, Yun
    Zhang, Kaining
    Dong, Shixiao
    Wang, Xiuhua
    Liu, Xinguang
    Ren, Yanjun
    Zhang, Ming
    Yan, Xinfeng
    Li, Jianmin
    Zhang, Lei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (07): : 2956 - 2968
  • [37] Decreased T helper 17 cells in tuberculosis is associated with increased percentages of programmed death ligand 1, T helper 2 and regulatory T cells
    Chin-Chung Shu
    Ming-Fang Wu
    Jann-Yuan Wang
    Hsin-Chih Lai
    Li-Na Lee
    Bor-Luen Chiang
    Chong-Jen Yu
    Respiratory Research, 18
  • [38] Th17 cells: The emerging reciprocal partner of regulatory T cells in the liver
    Zhao, Li
    Qiu, De Kai
    Ma, Xiong
    JOURNAL OF DIGESTIVE DISEASES, 2010, 11 (03) : 126 - 133
  • [39] Decreased T helper 17 cells in tuberculosis is associated with increased percentages of programmed death ligand 1, T helper 2 and regulatory T cells
    Shu, Chin-Chung
    Wu, Ming-Fang
    Wang, Jann-Yuan
    Lai, Hsin-Chih
    Lee, Li-Na
    Chiang, Bor-Luen
    Yu, Chong-Jen
    RESPIRATORY RESEARCH, 2017, 18
  • [40] Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma
    Marchenko, Sofya
    Piwonski, Iris
    Hoffmann, Inga
    Sinn, Bruno Valentin
    Kunze, Catarina Alisa
    Monje, Nanna
    Pohl, Jonathan
    Kulbe, Hagen
    Schmitt, Wolfgang Daniel
    Darb-Esfahani, Sylvia
    Braicu, Elena Ioana
    von Bruenneck, Ann-Christin
    Sehouli, Jalid
    Denkert, Carsten
    Horst, David
    Joehrens, Korinna
    Taube, Eliane Tabea
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2523 - 2536